Branded Generics Market Size And Share

  • Report Code : TIPRE00005554
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Branded Generics Market Share, Analysis, and Growth by 2031

Buy Now

Branded Generics Market Report Branded Generics Market Scope and Analysis Branded Generics Market Size and Share

Branded Generics Market: Strategic Insights

Branded Generics Market

  • CAGR (2023 - 2031)
    10.38%
  • Market Size 2023
    US$ 258.85 Billion
  • Market Size 2031
    US$ 570.40 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising Adoption of Branded Generics owing to their Affordability to Favor Market
  • Spurring government initiatives for the development of branded generics augmenting the market growth
FUTURE TRENDS
  • Utilization of Branded Generics by Healthcare Providers and Professionals
OPPORTUNITIES
  • Loss of Patent Exclusivity of Branded drugs and Emergence of Biosimilars Brings Future Opportunities

Key Players

  • Hetero
  • Aspen Holdings
  • Sandoz International GMBH
  • Par Pharmaceuticals INC
  • Dr Reddy s Laboratories
  • AstraZeneca PLC
  • Sanofi
  • Lupin
  • Bausch Health Companies Inc
  • GlaxoSmithKline plc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Therapeutic Application
  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Dermatology Diseases
  • Analgesics & Anti-Inflammatory
Drug Class
  • Alkylating Agents
  • Antimetabolites
  • Hormones
  • Antihypertensive
  • Lipid-Lowering Drugs
  • Antidepressants
  • Antipsychotics
  • Antiepileptic
Formulation Type
  • Oral
  • Parenteral
  • Topical
Distribution Channel
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores